📣 VC round data is live. Check it out!
- Public Comps
- Paul Hartmann
Paul Hartmann Valuation Multiples
Discover revenue and EBITDA valuation multiples for Paul Hartmann and similar public comparables like Menicon, Arjo, BioLife Solutions, Gerresheimer and more.
Paul Hartmann Overview
About Paul Hartmann
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Founded
1818
HQ

Employees
11.0K
Website
Sectors
Financials (FY)
EV
$1B
Valuation Multiples
Start free trialPaul Hartmann Financials
Paul Hartmann reported last fiscal year revenue of $3B and EBITDA of $276M.
In the same fiscal year, Paul Hartmann generated $2B in gross profit, $276M in EBITDA, and $72M in net income.
Paul Hartmann P&L
In the most recent fiscal year, Paul Hartmann reported revenue of $3B and EBITDA of $276M.
Paul Hartmann is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 10%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
Paul Hartmann Stock Performance
Paul Hartmann has current market cap of $849M, and enterprise value of $1B.
Market Cap Evolution
Paul Hartmann's stock price is $238.91.
Paul Hartmann share price increased by 0.2% in the last 30 days, and decreased by 14.1% in the last year.
Paul Hartmann has an EPS (earnings per share) of $20.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $849M | -0.2% | 0.2% | -6.3% | -14.1% | $20.28 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPaul Hartmann Valuation Multiples
Paul Hartmann trades at 0.4x EV/Revenue multiple, and 3.9x EV/EBITDA.
Paul Hartmann Financial Valuation Multiples
As of May 13, 2026, Paul Hartmann has market cap of $849M and EV of $1B.
Paul Hartmann has a P/E ratio of 11.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Paul Hartmann Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Paul Hartmann Margins & Growth Rates
In the most recent fiscal year, Paul Hartmann reported gross margin of 60%, EBITDA margin of 10%, and net margin of 2%.
Paul Hartmann Margins
Paul Hartmann Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Paul Hartmann Operational KPIs
Paul Hartmann's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Paul Hartmann Competitors
Paul Hartmann competitors include Menicon, Arjo, BioLife Solutions, Gerresheimer, Salus, Sopharma, Cerus, Shinva, Kestra Medical Technologies and Universal Vision.
Most Paul Hartmann public comparables operate across Medical Supplies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.2x | 1.3x | 8.3x | 8.0x | |||
| 0.6x | 0.6x | 3.7x | 3.7x | |||
| 10.3x | 9.7x | 40.1x | 37.1x | |||
| 1.4x | 1.3x | 7.2x | 7.0x | |||
| 0.7x | — | 16.7x | — | |||
| 0.7x | — | 7.6x | — | |||
| 2.2x | 2.2x | 55.0x | 39.8x | |||
| 0.7x | — | 7.5x | — | |||
This data is available for Pro users. Sign up to see all Paul Hartmann competitors and their valuation data. Start Free Trial | ||||||
Paul Hartmann M&A Activity
Paul Hartmann has acquired 1 company to date.
Last acquisition by Paul Hartmann was on January 2nd 2021. Paul Hartmann acquired pflege.de for undisclosed valuation.
Latest Acquisitions by Paul Hartmann
| Description | pflege.de is a Berlin-based platform connecting seniors with assisted living options, outpatient care, shared flats, and inpatient facilities throughout Germany. The service matches users with providers in over 400 cities, including Hamburg, Munich, and Cologne. pflege.de arranges counselor consultations, bathroom adaptations for mobility, stair lift installations, facility maintenance contracts, financial aid applications, and legal advice on care insurance. Its database lists 15,000 care homes and 5,000 ambulatory services. |
| HQ Country | |
| HQ City | Hamburg |
| Deal Date | 2 Jan 2021 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Paul Hartmann acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Paul Hartmann
| When was Paul Hartmann founded? | Paul Hartmann was founded in 1818. |
| Where is Paul Hartmann headquartered? | Paul Hartmann is headquartered in Germany. |
| How many employees does Paul Hartmann have? | As of today, Paul Hartmann has over 11K employees. |
| Is Paul Hartmann publicly listed? | Yes, Paul Hartmann is a public company listed on Stuttgart Stock Exchange. |
| What is the stock symbol of Paul Hartmann? | Paul Hartmann trades under PHH2 ticker. |
| When did Paul Hartmann go public? | Paul Hartmann went public in 2016. |
| Who are competitors of Paul Hartmann? | Paul Hartmann main competitors include Menicon, Arjo, BioLife Solutions, Gerresheimer, Salus, Sopharma, Cerus, Shinva, Kestra Medical Technologies, Universal Vision. |
| What is the current market cap of Paul Hartmann? | Paul Hartmann's current market cap is $849M. |
| What is the current revenue of Paul Hartmann? | Paul Hartmann's last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of Paul Hartmann? | Current revenue multiple of Paul Hartmann is 0.4x. |
| Is Paul Hartmann profitable? | No, Paul Hartmann is not profitable. |
| How many companies Paul Hartmann has acquired to date? | As of May 2026, Paul Hartmann has acquired 1 company. |
| What was the largest acquisition by Paul Hartmann? | None of the M&A deals Paul Hartmann has completed have disclosed valuations. |
| What companies Paul Hartmann acquired? | Paul Hartmann acquired pflege.de. |
| In how many companies Paul Hartmann has invested to date? | Paul Hartmann hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Paul Hartmann
Lists including Paul Hartmann
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
